Increased production of nitric oxide correlates with tumor growth in Algerian patients with nasopharyngeal carcinoma

Nasopharyngeal carcinoma (NPC) is thought to arise because of chronic inflammation. The correlation between nitric oxide (NO) production, a biomarker of inflammation and NPC development remains unexplored. To investigate this question, we performed a profile analysis on plasma collected from untreat...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Biomarkers Ročník 17; číslo 7; s. 618 - 624
Hlavní autori: Bourouba, Mehdi, Boukercha, Aziza, Zergoun, Ahmed-Amine, Zebboudj, Abderezak, Elhadjan, Mohamed, Djenaoui, Djamel, Asselah, Fatima, Touil-Boukoffa, Chafia
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: England Informa Healthcare 01.11.2012
Taylor & Francis
Predmet:
Adolescent
Adult
Algeria
biomarker
carcinogenesis
Carcinoma - blood
Carcinoma - pathology
Carcinoma - therapy
Case-Control Studies
Humans
inflammation
Middle Aged
Nasopharyngeal Carcinoma
Nasopharyngeal Neoplasms - blood
Nasopharyngeal Neoplasms - pathology
Nasopharyngeal Neoplasms - therapy
Neoplasm Recurrence, Local - blood
Neoplasm Recurrence, Local - pathology
Neoplasm Recurrence, Local - prevention & control
nitric oxide
Nitric Oxide - blood
Tumor Burden
UCNT
Young Adult
Algeria
ISSN:1354-750X, 1366-5804, 1366-5804
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Nasopharyngeal carcinoma (NPC) is thought to arise because of chronic inflammation. The correlation between nitric oxide (NO) production, a biomarker of inflammation and NPC development remains unexplored. To investigate this question, we performed a profile analysis on plasma collected from untreated, treated, remissive, cured and relapsing patients. Nitrites were measured to assess NO activity. We observed that increased nitrites concentrations in untreated and relapsing patients associated with tumor development. Moreover, nitrites levels were similar in remissive, cured and healthy individuals. Altogether, our results suggest that NO might be an interesting blood biomarker to monitor tumor growth in NPC patients.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1354-750X
1366-5804
1366-5804
DOI:10.3109/1354750X.2012.706643